AstraZeneca Shares Slide on $400bn Bristol Myers Merger Talks
AstraZeneca falls as investors question the value, risks and strategic logic behind a potential Bristol Myers deal.
AstraZeneca
Stay informed on AstraZeneca PLC (AZN) with the latest news, analysis, forecasts, and opinion pieces. Track AstraZeneca shares and market performance, all in one place.
AstraZeneca Shares Climb After Profit Beat and Dividend Hike
AstraZeneca lifts profit 30%, raises dividend, and beats forecasts on strong cancer drug sales.
AstraZeneca Shares Rise as CEO Eyes US Stock Market Move
AstraZeneca’s 2.6% share jump follows CEO’s US listing hint, another major blow to London’s stock market pride.